Patel, MD, PhD, of the University of Texas Southwestern Medical Center, breaks down QA102's first-in-class mechanism ...
Biogen’s Apellis acquisition consolidates a complement franchise spanning retinal and renal indications, with near-term label ...
Ultra-widefield pediatric retinal scans plus adaptable AI reveal hidden eye issues during routine visits, enabling ...
Two leading retinal specialists break down MCO-010's 3-year efficacy and safety data, the significance of contralateral eye ...
Nisha Acharya, MD, professor of Ophthalmology, Epidemiology, and Biostatistics at UCSF and member of the Francis I. Proctor ...
Caveolin‑1 is a membrane-associated protein expressed in many cell types that plays a key role in modulating inflammatory ...
A wireless intracortical architecture targets total blindness by circumventing nonfunctional retinas and optic nerves, ...
ALLUVIUM showed vamikibart Q8W/Q4W improved DME outcomes but underperformed ranibizumab for BCVA (+4.6 to +7.1 vs +13 letters ...
Single-shot optogenetic injection restores light sensitivity in advanced retinitis pigmentosa, delivering sustained vision gains for years with strong safety, expanding hope beyond gene-specific ...
According to MingMed Biotechnology, 1 the QA102-CS201 trial enrolled 150 patients with intermediate atrophic AMD and randomly ...
Sustained LLVA responder rates at 12 months reinforced the earlier 9-month signal and aligned with the endpoints selected for ...
A double-masked, randomized study in 20 healthy adults compared placebo versus single-drop atropine (0.01%–0.1%) across five ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results